Faculty Articles
Publication Title
Journal of Medicinal Chemistry
Publisher
American Chemical Society
ISSN
0022-2623
Publication Date
1-10-2019
Keywords
Allosteric Regulation, Bioluminescence Resonance Energy Transfer Techniques, Cyclic AMP, Dimerization, Drug Design, HEK293 Cells, Humans, Ligands, Models, Molecular, Receptors, Melanocortin, Signal Transduction, beta-Arrestin 2
Abstract
Understanding the functional relevance of G protein-coupled receptor (GPCR) homodimerization has been limited by the insufficient tools to assess asymmetric signaling occurring within dimers comprised of the same receptor type. We present unmatched bivalent ligands (UmBLs) to study the asymmetric function of melanocortin homodimers. UmBLs contain one agonist and one antagonist pharmacophore designed to target a melanocortin homodimer such that one receptor is occupied by an agonist and the other receptor by an antagonist pharmacophore. First-in-class biased UmBLs (BUmBLs) targeting the human melanocortin-4 receptor (hMC4R) were discovered. The BUmBLs displayed biased agonism by potently stimulating cAMP signaling (EC
DOI
10.1021/acs.jmedchem.8b00238
Volume
62
Issue
1
First Page
144
Last Page
158
Disciplines
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
NSUWorks Citation
Lensing, Cody J; Freeman, Katie T; Schnell, Sathya M; Speth, Robert Charles; Zarth, Adam T; and Haskell-Luevano, Carrie, "Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors." (2019). Faculty Articles. 113.
https://nsuworks.nova.edu/hpd_corx_facarticles/113
Comments
This work has been supported by NIH Grant R01DK091906 (C.H.-L.). C.J.L. and A.T.Z. was provided support from the University of Minnesota Doctoral Dissertation Fellowship. C.J.L. was provided additional the University of Minnesota College of Pharmacy Olsteins Graduate Fellowship. We would also like to acknowledge the receipt of a 2017 Wallin Neuroscience Discovery Fund Award.